- ￥3200 - 4600
- MedChemExpress(MCE)
- 美国
- HY-10017
- 2025年07月13日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
906805-42-3
- 规格：
5 mg/10 mg
| 规格： | 5 mg | 产品价格： | ￥3200.0 |
|---|---|---|---|
| 规格： | 10 mg | 产品价格： | ￥4600.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
SCH 546738
CAS No. : 906805-42-3
MCE 国际站：SCH 546738
产品活性：SCH 546738 是一种有效、可口服的非竞争性 CXCR3 拮抗剂，结合到人 CXCR3 受体的亲和常数 (Ki) 为 0.4 nM。
研究领域：GPCR/G Protein | Immunology/Inflammation
作用靶点：CXCR
In Vitro: The affinity of SCH 546738 binding to human CXCR3 receptor is determined by competition binding analysis using 35S radiolabeled SCH 535390 (a sulfonamide analog of the CXCR3 compound series with a Kd of 0.6 nM) as a competitive tracer. In addition, SCH 546738 displaces radiolabeled CXCL10 and CXCL11 from human CXCR3 with IC50 ranging from 0.8 to 2.2 nM in a non-competitive manner. SCH 546738 potently and specifically inhibits CXCR3-mediated chemotaxis in human activated T cells with IC90 about 10 nM.
In Vivo: SCH 546738 has strong cross-species activities with IC50 of 1.3 nM, 6.4 nM, 5.9 nM and 4.2 nM in inhibiting the binding of [125I]hCXCL10 to CXCR3 of monkey, dog, mouse and rat origin, respectively. SCH 546738 is a selective and potent CXCR3 antagonist with a good PK for in vivo studies.
相关产品：Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Immunology/Inflammation Compound Library | Small Molecule Immuno-Oncology Compound Library | Endocrinology Compound Library | Targeted Diversity Library | Chemokine Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | Cytokine Inhibitors Library | Plerixafor | SB225002 | AMG 487 | Kynurenic acid | Reparixin | AZD8797 | Navarixin | AZD-5069 | Motixafortide | TAK-779 | SX-682 | Decursin | Baohuoside I | NUCC-390 dihydrochloride | Mavorixafor trihydrochloride | NBI-74330 | Ladarixin | ML 145 | ML339 | ACT-1004-1239 | SB-265610 | VUF11207 fumarate | CXCR7 antagonist-1 | IT1t dihydrochloride | Danirixin | LY2510924 | PS372424 hydrochloride | TC14012
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验疟原虫 Malaria Parasites(Plasmodium)
in one massGametocyte distorted by parasitecrescent or sausage shape; chromatin in a single mass (macrogametocyte) or diffuse (microgametocyte); dark pigment massP. vivax Ring normal to 11/4 X, round; occasionally fine Schüffner's dots; multiple infection
Dopamine Receptor Binding and Quantitative Autoradiographic Study
and extensively used to characterize the classical dopamine receptor subtypes. These radioligands include the D1 -selective ligands [3 H]SCH 23390 and [125 I]SCH 23982. D2 receptor-selective ligands include the antagonists [3 H]spiperone, [3 H]YM 09151-2, and [125
Fluorescence Correlation Spectroscopy (FCS)-Based Characterisation of Aptamer Ligand Interaction
target and its corresponding RNA aptamer selected via systematic evolution of ligands by exponential enrichment (SELEX) (Sch�rer, et al. (2001) Biol. Chem . 382 , 47948). Here, an FCS titration experiment is described in detail, where the binding
技术资料暂无技术资料 索取技术资料
